This large sector covers the production and sale of consumer goods, as well as various consumer services including electronic commerce and health care. Since 1996, Baring Vostok funds have invested over $400 million in 13 companies from this sector.
Location:
Saint Petersburg, Russia
Years:
2016
Shareholding:
Minority stake

Solopharm is a producer of pharmaceuticals, with focus on liquid drugs production. Product portfolio of Solopharm includes infusions, injectables, and a number of emerging branded products — ophthalmological drugs, nasal forms. All the drugs are generic drugs. Products are sold both to Russian hospitals and to pharmacies. The Company operates modern production facility located in Saint-Petersburg.

Other projects

News

02 September 2019

Media Statement.

Baring Vostok statement on the court decision to arrest Evison’s remaining shares of Vostochny Bank.
15 August 2019

Media Statement.

Mosgorsud took the only possible reasonable decision today, transferring Philippe Delpal to house arrest. The court also claified some of the restrictions relating to Michael Calvey’s continued house arrest.
06 August 2019

Media Statement.

BVCP statement on the decision by Mosgorsud on 5 August 2019.
10 July 2019

Media Statement.

At today’s hearing in the Basmanniy Court the defense lawyers for Ivan Zyuzin and Vagan Abgaryan announced a motion to disqualify the judge after spotting the ruling for the hearing on the judge’s desk before the hearing had even completed.
09 July 2019

Media Statement.

Today’s decision by the Basmanniy Court to prolong the pre-trial detentions of Maxim Vladimirov and Philippe Delpal was unfounded.

08 July 2019

Media Statement.

Today the Basmanny Court once again prolonged the house arrest of the founder of Baring Vostok Michael Calvey, without any legal basis for the arrest.

14 June 2019

Media Statement.

Baring Vostok funds are very concerned about potential violations with the bank’s formal approach to meeting the Central Bank requirements, and about continuing issues with Vostochny’s asset quality that may require an additional RUB 10-15 billion of provisions be created.
21 May 2019

Media Statement.

BVCP statement on the decision to deny Philippe Delpal’s appeal regarding the form of pre-trial detention.